This study describes the antimycobacterial activity of new quinoxaline derivatives against clinical isolates of Mycobacterium tuberculosis and other mycobacteria (M. bovis, M. cheloneae, M. avium sub. paratuberculosis). Isolates were collected in the Department of Biomedical Science (Sassari University). One of the most important steps of tuberculosis pathogenesis is the infection of alveolar macrophages and so for this reason, we observed the intracellular action of these drugs in mouse macrophages.
In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria / Zanetti, Stefania Anna Lucia; Sechi, Leonardo Antonio; Molicotti, Paola; Cannas, Sara; Bua, A; Deriu, A; Carta, Antonio; Paglietti, G.. - In: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. - ISSN 0924-8579. - 25(2)::(2005), pp. 179-181.
In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria
ZANETTI, Stefania Anna Lucia;SECHI, Leonardo Antonio;MOLICOTTI, Paola;CANNAS, Sara;CARTA, Antonio;
2005-01-01
Abstract
This study describes the antimycobacterial activity of new quinoxaline derivatives against clinical isolates of Mycobacterium tuberculosis and other mycobacteria (M. bovis, M. cheloneae, M. avium sub. paratuberculosis). Isolates were collected in the Department of Biomedical Science (Sassari University). One of the most important steps of tuberculosis pathogenesis is the infection of alveolar macrophages and so for this reason, we observed the intracellular action of these drugs in mouse macrophages.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
